Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    "Erysipelas"
Show Display Options
Rank Status Study
1 Terminated Short Course of Amoxicillin for Erysipelas
Condition: Erysipelas
Intervention: Drug: Amoxicillin
2 Completed RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg
Condition: Cellulitis/Erysipelas of the Leg
Interventions: Drug: Penicillin VK;   Other: placebo
3 Unknown  The Use of Oral Steroids in the Treatment of Cellulitis
Conditions: Cellulitis;   Erysipelas
Intervention: Drug: Prednisone
4 Completed Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas
Condition: Cellulitis
Interventions: Drug: Daptomycin;   Drug: Vancomycin
5 Recruiting Duration of ANtibiotic Therapy for CEllulitis
Conditions: Cellulitis;   Erysipelas
Interventions: Drug: Flucloxacillin;   Drug: Placebo (for flucloxacillin)
6 Completed
Has Results
A Phase 2 Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study
Conditions: Major Cutaneous Abscess;   Cellulitis;   Erysipelas
Intervention: Drug: TR701 FA
7 Recruiting Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo
Conditions: Erysipelas;   Impetigo;   Herpes Zoster;   Molluscum Contagiosum;   Warts;   Tinea;   Melanoma;   Actinic Keratosis;   Basal Cell Carcinoma;   Squamous Cell Carcinoma
Interventions: Procedure: Screening;   Device: Tele-dermatology
8 Completed Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
Conditions: Skin Infection;   Bacterial Infection
Interventions: Drug: Daptomycin;   Drug: Brilacidin

Study has passed its completion date and status has not been verified in more than two years.